Introduction
V1-X™ leverages the fast-growing marine bacterium Vibrio natriegens to outperform traditional E. coli systems. With ~14-minute doubling, tight IPTG control, and up to 60× more soluble protein on difficult targets, V1-X™ is a new workhorse for cytoplasmic, membrane-bound, and secreted expression.
Key Features
Fast
Doubles in ~14 minutes (vs. ~30 min for E. coli)
Doubles in ~14 minutes (vs. ~30 min for E. coli)
High Yield
Up to 60× more protein expression for hard targets
Up to 60× more protein expression for hard targets
Scalable
Works from high-throughput screens to large-volume prep
Works from high-throughput screens to large-volume prep
Flexible
Compatible with pet vectors, 25–37°C conditions
Compatible with pet vectors, 25–37°C conditions
Easy
Safe (BSL1), compatible with standard workflows
Safe (BSL1), compatible with standard workflows
Cleaner
Up to 100× lower endotoxins than E. coli
Up to 100× lower endotoxins than E. coli
Applications
Strain Engineering
Exploit rapid doubling and high transformation efficiency to accelerate strain construction and pathway optimization—ideal for faster design–build–test cycles without sacrificing yield or stability.
Gene Therapy Vectors
Build and test high-quality vectors quickly. V1-X™ supports large-scale plasmid production with high yield and purity, reducing downstream processing and enabling more iterations in less time.
DNA & Protein Expression
Produce exceptional titers for tough targets, including membrane proteins and toxic constructs. V1-X™’s engineered physiology and growth kinetics shorten fermentation runs and improve reproducibility.
Specifications
Launching in 2026
Sign up to be first to access V1-X™—our next-gen expression strain delivering ~2× growth speed and up to 60× yield.
- Choosing a selection results in a full page refresh.